- Joined
- Aug 14, 2010
- Messages
- 572
This study will run in centers in Germany, Denmark, Austria, Czech Republic, and Switzerland, only.
This proof-of-concept study aims to evaluate the efficacy of three doses of oral TSO suspension vs. placebo for the induction of remission in Crohn's disease.
Phase II
Contacts
Contact: Ralph Müller, Dr ++49-761-1514 ext 0 [email protected]
2011
http://clinicaltrials.gov/ct2/show/NCT01279577
This proof-of-concept study aims to evaluate the efficacy of three doses of oral TSO suspension vs. placebo for the induction of remission in Crohn's disease.
Phase II
Contacts
Contact: Ralph Müller, Dr ++49-761-1514 ext 0 [email protected]
2011
http://clinicaltrials.gov/ct2/show/NCT01279577
